CLNICAL TRIALS WARSZAW

MD

Rafał Ptaszyński

rheumatologist

Education

2011

Rheumatology Specialist

2008

Internal Medicine Specialist

2000

Degree I – Internal Medicine

1990-1996

Medical University of Bydgoszcz – Faculty of Medicine

Professional Experience

1997-1998

Junior assistant at the Neurology Department of the Provincial Hospital in Koszalin

from 1998

Assistant, and then senior assistant at the Rheumatology Clinic and Polyclinic of the Institute of Rheumatology in Warsaw

Achievements

Over the years

Participation in dozens of international clinical trials, Phases I-IV, for rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, ankylosing spondylitis, osteoporosis, and osteoarthritis

Over the years

Participation in numerous conferences, meetings, congresses, symposia, and training courses in rheumatology

Membership

Member of the Polish Rheumatology Society

Publikacje naukowe

Treatment with BI 655064 (antagonistic anti-CD40 antibody) modulates clinical and biomarker parameters associated with rheumatoid arthritis (RA).

S. Visvanathan, M. Ramanujam, C. Schoelch, P. Baum, R. Vinisko, R. Thiedmann, U. Müller-Ladner, S. Daniluk, R. Ptaszynski, S. Padula, J.S Fine, J. Steffgen. American College of Rheumatology, 2016.

Opioidy w leczeniu bólu u chorych na choroby reumatyczne. (eng .”Opiates in the management of pain in rheumatic diseases”).

A. Zubrzycka–Sienkiewicz, R. Ptaszyński. Terapia, 2006; 175 (2) 39-45.

Postępowanie w bólu reumatycznym (eng Pain managenent in rheumatic diseases).

Zubrzycka–Sienkiewicz, R. Ptaszyński. Med. Po Dypl., 2005; 14 (9):16-36.

“Fibromialgia”

Rafał Ptaszyński. Lek w Polsce, Vol 12, NR 12’02 (144).